Repare Therapeutics Inc. (RPTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.6500 |
| Open | 3.6500 |
| Bid | 3.4300 x 100 |
| Ask | 3.5400 x 100 |
| Day's range | 3.3500 - 3.7100 |
| 52-week range | 3.0800 - 13.8500 |
| Volume | |
| Avg. volume | 128,990 |
| Market cap | 146.372M |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.2300 |
| Earnings date | 26 Feb 2024 - 01 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 17.67 |
Simply Wall St.Repare Therapeutics Full Year 2023 Earnings: Misses Expectations
Repare Therapeutics ( NASDAQ:RPTX ) Full Year 2023 Results Key Financial Results Revenue: US$51.1m (down 61% from FY...
- Business Wire
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
CAMBRIDGE, Mass. & MONTREAL, February 29, 2024--Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate at two upcoming investor conferences. Details for the presentations are as follows.
GuruFocus.comRepare Therapeutics Inc (RPTX) Reports Financial Outcomes for Q4 and Full Year 2023
Strategic Progress Amidst Financial Challenges
© 2024 Yahoo. All rights reserved.